Resource Guide

Moradec LLC, founded in 2012 by Helen (Hongyuan) Mao, PhD, provides novel research tools. The company's novel secondary antibody-drug conjugates (2°ADCs) are used as a...

Researchers and engineers at Mersana develop novel drug conjugates that maximize the potential of new and established therapeutic classes. The company's technology harnesses the...

Merrimack is a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of cancer. The company seeks...

Meditope Biosciences is a biotechnology company developing best-in-class antibody-based cancer products. Discovered at City of Hope National Medical Center (a private, not-for-profit clinical research...

MacroGenics is a leader in the discovery and development of innovative medicinces that utilize the next generation antibody-based technologies. With a team of 150+...

Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds.  By combining the unique targeting of...

Intellect Neurosciences, Inc. develops innovative approaches aimed at arresting or preventing Alzheimer's disease and other neurodegenerative diseases, with a specific focus on proteinopathies. Intellect's...

Innate Pharma, a French biopharmaceutical company founded in 1999, is developing first-in-class immunotherapy drugs for cancer and inflammatory diseases. The company's drug-candidates belong to...

Immunomedics is a New Jersey-based biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other...

ImmunoGen, Inc. develops targeted anticancer therapeutics. The company's proprietary Targeted Antibody Payload (TAP) technology and strong antibody expertise form the basis for our development...